Mark Pruzanski
2016
In 2016, Mark Pruzanski earned a total compensation of $4.8M as President and Chief Executive Officer at Intercept Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $347,000 |
|---|---|
| Option Awards | $1,608,449 |
| Salary | $620,000 |
| Stock Awards | $2,196,957 |
| Other | $4,627 |
| Total | $4,777,033 |
Pruzanski received $2.2M in stock awards, accounting for 46% of the total pay in 2016.
Pruzanski also received $347K in non-equity incentive plan, $1.6M in option awards, $620K in salary and $4.6K in other compensation.
Rankings
In 2016, Mark Pruzanski's compensation ranked 1,725th out of 14,075 executives tracked by ExecPay. In other words, Pruzanski earned more than 87.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,725 out of 14,075 | 88th |
Division Manufacturing | 587 out of 5,489 | 89th |
Major group Chemicals And Allied Products | 164 out of 1,895 | 91st |
Industry group Drugs | 113 out of 1,538 | 93rd |
Industry Pharmaceutical Preparations | 89 out of 1,176 | 92nd |
Source: SEC filing on April 27, 2018.
Pruzanski's colleagues
We found two more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2016.